Stevanato Group SpA
STVN
View Detailed Chart
20.550USD
+0.030+0.15%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
5.61BMarket Cap
46.74P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.15%
5 Days
-1.30%
1 Month
-2.88%
6 Months
-11.76%
Year to Date
-5.69%
1 Year
-0.05%
View Detailed Chart
TradingKey Stock Score of Stevanato Group SpA
Currency: USD Updated: 2025-12-19Key Insights
Stevanato Group SpA's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 63/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.99.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Stevanato Group SpA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
28.993
Target Price
+34.98%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Stevanato Group SpA Highlights
StrengthsRisks
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.27%.
Undervalued
The company’s latest PE is 46.70, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 55.80M shares, decreasing 15.95% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 945.00 shares of this stock.
Stevanato Group SpA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Stevanato Group SpA Info
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Ticker SymbolSTVN
CompanyStevanato Group SpA
CEOStevanato (Franco)
Websitehttps://www.stevanatogroup.com/
FAQs
What is the current price of Stevanato Group SpA (STVN)?
The current price of Stevanato Group SpA (STVN) is 20.550.
What is the symbol of Stevanato Group SpA?
The ticker symbol of Stevanato Group SpA is STVN.
What is the 52-week high of Stevanato Group SpA?
The 52-week high of Stevanato Group SpA is 28.000.
What is the 52-week low of Stevanato Group SpA?
The 52-week low of Stevanato Group SpA is 17.810.
What is the market capitalization of Stevanato Group SpA?
The market capitalization of Stevanato Group SpA is 5.61B.
What is the net income of Stevanato Group SpA?
The net income of Stevanato Group SpA is 117.78M.
Is Stevanato Group SpA (STVN) currently rated as Buy, Hold, or Sell?
According to analysts, Stevanato Group SpA (STVN) has an overall rating of Buy, with a price target of 28.993.
What is the Earnings Per Share (EPS TTM) of Stevanato Group SpA (STVN)?
The Earnings Per Share (EPS TTM) of Stevanato Group SpA (STVN) is 0.440.
Related Instruments
-0.24%
+0.25%
+0.87%
+1.88%
+0.22%
-0.55%
+0.53%
+0.12%
+1.35%
-0.10%
-1.23%
-0.77%
+0.10%
+0.46%
+0.46%
+0.97%
+0.59%
+0.23%
+0.45%
+1.74%
